Astrana Health (NASDAQ:ASTH) Upgraded at Macquarie

Macquarie upgraded shares of Astrana Health (NASDAQ:ASTH) to a hold rating in a report published on Monday morning,Zacks.com reports.

ASTH has been the subject of a number of other research reports. TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price target for the company. KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Robert W. Baird increased their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, BTIG Research lifted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $65.17.

Astrana Health Stock Down 1.4 %

NASDAQ:ASTH opened at $35.04 on Monday. Astrana Health has a 1 year low of $34.11 and a 1 year high of $63.20. The stock has a 50-day moving average price of $48.57 and a two-hundred day moving average price of $48.08. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 26.95, a PEG ratio of 1.80 and a beta of 1.13. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. The business had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period last year, the business posted $0.47 earnings per share. As a group, equities analysts expect that Astrana Health will post 1.16 earnings per share for the current year.

Institutional Investors Weigh In On Astrana Health

Large investors have recently modified their holdings of the business. GAMMA Investing LLC bought a new stake in Astrana Health during the 3rd quarter worth $34,000. Nisa Investment Advisors LLC bought a new stake in Astrana Health during the 3rd quarter worth approximately $35,000. KBC Group NV acquired a new position in Astrana Health in the 3rd quarter valued at approximately $70,000. Quarry LP bought a new position in shares of Astrana Health during the third quarter valued at $77,000. Finally, Quest Partners LLC acquired a new stake in Astrana Health in the third quarter valued at $133,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.